New York Life Investment Management LLC Reduces Position in Docusign Inc. $DOCU

New York Life Investment Management LLC cut its stake in shares of Docusign Inc. (NASDAQ:DOCU) by 2.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,411 shares of the company’s stock after selling 436 shares during the quarter. New York Life Investment Management LLC’s holdings in Docusign were worth $1,668,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the stock. Oak Family Advisors LLC boosted its holdings in Docusign by 37.2% in the second quarter. Oak Family Advisors LLC now owns 95,134 shares of the company’s stock valued at $7,410,000 after purchasing an additional 25,795 shares during the last quarter. New Age Alpha Advisors LLC boosted its holdings in Docusign by 738.2% in the first quarter. New Age Alpha Advisors LLC now owns 41,187 shares of the company’s stock valued at $3,353,000 after purchasing an additional 36,273 shares during the last quarter. Pinpoint Asset Management Ltd boosted its holdings in Docusign by 54.3% in the first quarter. Pinpoint Asset Management Ltd now owns 56,985 shares of the company’s stock valued at $4,639,000 after purchasing an additional 20,043 shares during the last quarter. Concurrent Investment Advisors LLC purchased a new stake in Docusign in the first quarter valued at $618,000. Finally, QRG Capital Management Inc. boosted its holdings in Docusign by 6.6% in the second quarter. QRG Capital Management Inc. now owns 70,583 shares of the company’s stock valued at $5,498,000 after purchasing an additional 4,341 shares during the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

Docusign Stock Up 2.1%

DOCU opened at $73.14 on Friday. The company has a market cap of $14.71 billion, a PE ratio of 54.99, a price-to-earnings-growth ratio of 3.56 and a beta of 1.02. Docusign Inc. has a twelve month low of $66.35 and a twelve month high of $107.86. The company has a 50-day moving average price of $75.16 and a 200 day moving average price of $77.72.

Docusign (NASDAQ:DOCU) last released its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The business had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. During the same period last year, the company posted $0.97 EPS. The business’s revenue was up 8.8% on a year-over-year basis. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, sell-side analysts expect that Docusign Inc. will post 1.17 earnings per share for the current year.

Insiders Place Their Bets

In other Docusign news, insider James P. Shaughnessy sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $71.19, for a total value of $533,925.00. Following the transaction, the insider directly owned 55,442 shares of the company’s stock, valued at $3,946,915.98. This trade represents a 11.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Peter Solvik sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $81.48, for a total transaction of $1,222,200.00. Following the completion of the transaction, the director directly owned 135,253 shares in the company, valued at $11,020,414.44. This trade represents a 9.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 102,533 shares of company stock worth $7,709,933. 1.01% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Robert W. Baird upped their price target on shares of Docusign from $85.00 to $90.00 and gave the company a “neutral” rating in a report on Friday, September 5th. JMP Securities reissued a “market outperform” rating and set a $124.00 target price on shares of Docusign in a research note on Friday, October 3rd. Evercore ISI increased their target price on shares of Docusign from $90.00 to $92.00 and gave the stock an “in-line” rating in a research note on Friday, September 5th. Wall Street Zen raised shares of Docusign from a “hold” rating to a “buy” rating in a research note on Saturday, September 13th. Finally, Zacks Research raised shares of Docusign from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, September 9th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fifteen have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $94.14.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.